Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study.
Goig GA, Menardo F, Salaam-Dreyer Z, Dippenaar A, Streicher EM, Daniels J, Reuter A, Borrell S, Reinhard M, Doetsch A, Beisel C, Warren RM, Cox H, Gagneux S. Goig GA, et al. Among authors: daniels j. Lancet Microbe. 2023 Jul;4(7):e506-e515. doi: 10.1016/S2666-5247(23)00110-6. Epub 2023 Jun 6. Lancet Microbe. 2023. PMID: 37295446 Free PMC article.
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
Salaam-Dreyer Z, Streicher EM, Sirgel FA, Menardo F, Borrell S, Reinhard M, Doetsch A, Cudahy PGT, Mohr-Holland E, Daniels J, Dippenaar A, Nicol MP, Gagneux S, Warren RM, Cox H. Salaam-Dreyer Z, et al. Among authors: daniels j. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0036421. doi: 10.1128/AAC.00364-21. Epub 2021 Aug 30. Antimicrob Agents Chemother. 2021. PMID: 34460307 Free PMC article.
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.
Cox H, Salaam-Dreyer Z, Goig GA, Nicol MP, Menardo F, Dippenaar A, Mohr-Holland E, Daniels J, Cudahy PGT, Borrell S, Reinhard M, Doetsch A, Beisel C, Reuter A, Furin J, Gagneux S, Warren RM. Cox H, et al. Among authors: daniels j. Lancet Microbe. 2021 Nov;2(11):e584-e593. doi: 10.1016/S2666-5247(21)00144-0. Lancet Microbe. 2021. PMID: 34766068 Free PMC article.
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study.
Cox H, Goig GA, Salaam-Dreyer Z, Dippenaar A, Reuter A, Mohr-Holland E, Daniels J, Cudahy PGT, Nicol MP, Borrell S, Reinhard M, Doetsch A, Beisel C, Gagneux S, Warren RM, Furin J. Cox H, et al. Among authors: daniels j. J Clin Microbiol. 2022 Mar 16;60(3):e0236221. doi: 10.1128/jcm.02362-21. Epub 2022 Mar 16. J Clin Microbiol. 2022. PMID: 35170980 Free PMC article.
Household contact management for rifampicin-resistant tuberculosis.
Reuter A, Apolisi I, Daniels J, Furin J, Cox H. Reuter A, et al. Among authors: daniels j. Lancet Glob Health. 2022 Oct;10(10):e1387. doi: 10.1016/S2214-109X(22)00362-X. Lancet Glob Health. 2022. PMID: 36113520 Free article. No abstract available.
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa.
Mohr E, Hughes J, Reuter A, Trivino Duran L, Ferlazzo G, Daniels J, De Azevedo V, Kock Y, Steele SJ, Shroufi A, Ade S, Alikhanova N, Benedetti G, Edwards J, Cox H, Furin J, Isaakidis P. Mohr E, et al. Among authors: daniels j. Eur Respir J. 2018 Jun 14;51(6):1800017. doi: 10.1183/13993003.00017-2018. Print 2018 Jun. Eur Respir J. 2018. PMID: 29724920 Free PMC article.
Early mortality during rifampicin-resistant TB treatment.
Mohr-Holland E, Daniels J, Reuter A, Rodriguez CA, Mitnick C, Kock Y, Cox V, Furin J, Cox H. Mohr-Holland E, et al. Among authors: daniels j. Int J Tuberc Lung Dis. 2022 Feb 1;26(2):150-157. doi: 10.5588/ijtld.21.0494. Int J Tuberc Lung Dis. 2022. PMID: 35086627 Free PMC article.
Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household.
Apolisi I, Cox H, Tyeku N, Daniels J, Mathee S, Cariem R, Douglas-Jones B, Ngambu N, Mudaly V, Mohr-Holland E, Isaakidis P, Pfaff C, Furin J, Reuter A. Apolisi I, et al. Among authors: daniels j. Open Forum Infect Dis. 2023 Feb 21;10(3):ofad087. doi: 10.1093/ofid/ofad087. eCollection 2023 Mar. Open Forum Infect Dis. 2023. PMID: 36910692 Free PMC article.
Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa".
Mohr-Holland E, Reuter A, Hughes J, Daniels J, Beko B, Makhanda G, De Avezedo V, Kock Y, Cox H, Furin J, Trivino Duran L, Isaakidis P, Ferlazzo G. Mohr-Holland E, et al. Among authors: daniels j. Eur Respir J. 2020 Jul 23;56(1):2000837. doi: 10.1183/13993003.00837-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32703820 Free article. No abstract available.
1,897 results